Success Stories: Chinese Assistant Professor Earns NIW Approval for Advancing AI and Biostatistical Models in Disease Prediction

Client’s Testimonial:

“Thank you so much for your help and support throughout the process. I really appreciate your excellent work.”

On October 22^nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the field of Biostatistics (Approval Notice).

General Field: Biostatistics

Position at the Time of Case Filing: Assistant Professor

Country of Origin: China

State of Residence at the Time of Filing: Louisiana

Approval Notice Date: October 22^nd, 2025

Processing Time: 5 months, 13 days (Premium Processing Requested)

Case Summary:

We are pleased to share the NIW approval of an assistant professor from China whose research integrates biostatistics, artificial intelligence, and genomics to advance personalized medicine. At the time of filing, he was developing AI-powered statistical methods to analyze large-scale genetic data for predicting chronic disease risks. With a strong record of publications, citations, and federal funding support, he presented an outstanding case for NIW approval.

Research with Substantial Merit and National Importance

The client’s proposed endeavor focuses on building statistical and AI models that identify genetic and environmental factors contributing to diseases such as diabetes, Alzheimer’s, and cardiovascular conditions. His work directly supports U.S. priorities in early disease detection and preventive healthcare while reducing treatment costs and improving outcomes.

By enhancing the accuracy of biomedical data analysis, his research contributes to initiatives by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to advance precision medicine and strengthen national health infrastructure.

Academic Contributions and Recognition

The client holds a Ph.D. in biostatistics and has authored 7 peer-reviewed journal articles, 2 preprints, 2 conference abstracts, and 2 patents (one granted, one pending). His studies, published in journals such as Briefings in Bioinformatics and Function, have been cited 94 times, with multiple papers ranked among the top 10–20% most cited in molecular biology and genetics.

He has also completed at least two peer reviews for leading journals such as Bioinformatics and Genetic Epidemiology, underscoring his recognition as an expert in his field. His research has received support from the National Science Foundation (NSF), the National Institutes of Health (NIH), and the Department of Defense, confirming its national importance.

Expert Recognition

Independent experts praised the originality and impact of his work.

One recommender noted:

“Based on my knowledge of his skills and past research, I expect [client] will make a significant impact on biomedical research and data science, and his permanent residence would greatly advance the health and technology priorities of our nation.”

This statement captures the scientific and societal relevance of his research.

NIW Approval and Outlook

The I-140 NIW petition was filed on May 9, 2025, upgraded to premium processing, and approved on October 22, 2025. With NAILG’s support, the client secured NIW approval and continues his research in the United States. His ongoing work in statistical modeling and artificial intelligence will strengthen disease prevention strategies and reinforce U.S. leadership in biomedical innovation.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.